You are here
Phenotyping Steering Group
The Phenotyping Steering Group plays a role in assessing and developing phenotyping approaches within the IMPC pipeline
, including:
- Establishing a series of technical meetings to look at how tests are working, baseline data and phenotypes detected.
- Developing the IMPC Business Plan with respect to future phenotyping developments.
Name | Institute |
---|---|
Karen Svenson* | The Jackson Laboratory |
Yann Herault* | Institut Clinique de la Souris |
Ann Flenniken | Toronto Centre for Phenogenomics |
Corey Reynolds | Baylor College of Medicine |
David West | Children's Hospital Oakland Research Institute |
Jacqui White | The Wellcome Trust Sanger Institute |
Je Kyung Seong | Korea Mouse Phenotyping Consortium |
Mark Henkelman | Toronto Centre for Phenogenomics |
Mohammed Selloum | Institut Clinique de la Souris |
Monica Justice | Baylor College of Medicine |
Nick Gale | Regeneron |
Sara Wells | Medical Research Council Harwell |
Shigeharu Wakana | RIKEN BioResource Centre |
Tania Sorg-Guss | Institut Clinique de la Souris |
Valerie Gailus-Durner | Helmholtz Zentrum Muenchen/Infrafrontier |
*Committee co-chairs |